Integrated Biology Platform
Delivering comprehensive solutions from early discovery through IND-enabling translational studies
Peptide & Aptamer Screening
PRECEDO's Screening Libraries & Hit Discovery platform delivers end-to-end peptide and aptamer screening against a broad spectrum of target classes — from small molecules and purified proteins to complex biological entities such as exosomes, viruses, and intact cells.
Platform Strengths
- Core team with 10+ years of SELEX screening experience per scientist
- 150+ completed projects across diverse target classes; >95% success rate over the past 3 years
- 1,000+ patient samples available for selection and clinical validation studies
| Library | Type | Diversity | Status |
| Ph.D. TM-C7C | Phage | 109 | Ready to use |
| Ph.D. TM-12 | Phage | 109 | Ready to use |
| Ph. D. CX12C | Phage | 1010 | Ready to use |
| CX8C | RNA | 1010 | Ready to use |
| CX10C | RNA | 1013 | Ready to use |
| CX12C | RNA | 1014 | Ready to use |
| CX14C | RNA | 1014 | Ready to use |
| X3CX8CX3 | RNA | 1014 | Ready to use |